![]() |
Volumn 196, Issue 3, 2012, Pages 158-
|
A healthy dose of disinvestment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
BIOMEDICAL TECHNOLOGY ASSESSMENT;
CONSENSUS DEVELOPMENT;
COST BENEFIT ANALYSIS;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DISINVESTMENT;
DRUG EFFICACY;
DRUG SAFETY;
EVIDENCE BASED MEDICINE;
GOVERNMENT REGULATION;
HEALTH CARE FINANCING;
HEALTH CARE MANAGEMENT;
HEALTH CARE POLICY;
HEALTH ECONOMICS;
MEDICARE;
OPHTHALMOLOGY;
OUTCOME ASSESSMENT;
PERCUTANEOUS VERTEBROPLASTY;
PRACTICE GUIDELINE;
ADVISORY COMMITTEES;
AUSTRALIA;
COST-BENEFIT ANALYSIS;
EVIDENCE-BASED MEDICINE;
HEALTH EXPENDITURES;
HUMANS;
NATIONAL HEALTH PROGRAMS;
POLICY MAKING;
PROGRAM EVALUATION;
|
EID: 84857829638
PISSN: 0025729X
EISSN: 13265377
Source Type: Journal
DOI: 10.5694/mja12.10011 Document Type: Article |
Times cited : (3)
|
References (7)
|